 |
| How Protocol Design Drives Comparator Sourcing Cost, Timelines, Complexity, and Risk |
| Clinical trial protocol design can have a significant positive or negative impact on the eventual commercial drug sourcing strategy needed to successfully acquire the comparator drugs needed to execute the study. Early input into the development of the protocol—which considers the need to source commercial products for use in the study—can potentially impact the costs, timelines, operational complexity, and overall risk incurred when sourcing comparators. |
 |
| How detailed should the description of the needed comparator(s) be in the protocol? Should specific countries of origin should be named? Are there other drug characteristic variables that should be considered? Should sourcing be done centrally or regionally? This webcast will address these and other questions that should be considered before a trial protocol is finalized. |
 |
Sponsored by: |
